Список цитируемой и рекомендуемой литературы


Bremner W. J., Paulsen С. A. Colchicine and testicular function in man. — New Engl. J. Med., 1976, 294, 1384.

Ertel M. H., Miller J. C, Akgun S., Wallace S. L. Radioimmunoassay for colchicine in plasma and urine. — Science, 1976, 193, 233.

Goldfinger S. E. Colchicine for familial Meditarranean fever — New Engl. J. Med., 1972, 287, 1302.

Spilberg I., Mandell В., Mehta J. et al. Mechanism of action of colchicine inacute urate crystal-induced arthritis. — J. clin. Investigation, 1979, 64, 775.

Wallace S. L. Colchicine Seminars in Arthritis and Rheumatism, 1974, 3, 369.

Yu T.-F., Gutman A. B. Efficacy of colchicine prophylaxis in gout. — Ann. intern. med, 1961, 55, 179.


Dayton P. G., Perel J. M. The metabolism of probenecid in man. — Ann. N. Y.

Acad. Sci., 1971, 179, 399. Gutman А. В., Yu T.-F. Protracted uricosuric therapy in tophaceous gout. — Lancet, 1957, 2, 1256.

Kippen I., Whitehouse M. W., Kllnenberg M. W. Pharmacology of uricosuric drugs. — Ann. rheumat. Dis., 1974, 33, 391.

Yu T.-F., Gutman A. B. Paradoxical retention of uric acid by uricosuric drugs in low dosage. — Proc. Soc. exp. Biol. (N. Y.), 1955, 90, 542.


Anturane Reinfarction Trial Research Group: Sulfinpyrazone in the prevention of sudden death after myocardial infarction. — New Engl. J. Med., 1980, 302, 250.

Dieterle W., Faigle J. W., Могу Н. et al. Biotransformation and pharmacokinetics of sulphinpyrazone in man. — Clin. Pharmacol., 1975, 9, 135.

Emmerson В. Т. A comparison of uricosuric agents in gout with special to sulphinpyrazone. — Med. J. ef Australia, 1963, 1, 839.

Perel J. M., Dayton P. G., Snell M. M. et al. Studies of interactions among

drugs in man at the renal level: Probenecid and sulphinpyrazone. — Clin. Pharmacol. Therapeutics, 1969, 10, 834.

Smythe H. A., Ogryzio M. A., Murphy E. A., Mustard J. F. The effect of sulphinpyrazone (Anurane) on platelet economy and blood coagulation in man. — Canad. med. Association J., 1965, 92, 818.

Yu T.-F., Dayton P. G., Gutman A. B. Mutual suppression of the uricosuric effects of sulfinpyrazone and salicylate: A study in interactions between drugs. — J. clin. Investigation, 1963, 42, 1330.


Сое F. L., Kavalach A. G. Hypercalcinuria and hyperuricosuria in patients with calcium nephrolithiasis. — New Engl. J. med., 1974, 291, 1344.

Fox R. M., Royce-Smith D., OSullivan W. J. Orotidinuria induced by allopurinol. — Science, 1970, 168, 861.

Frisch J. M., Lovatt G. E., Sproit A. R. M., Turmer P. The Adverse Reaction Profile of Allopurinol. Proceedings of the 12th International Congress of Internal Medicine, 1974, 412 — 419.

Kantor G. L. Toxic epidermal necrolysis, azotemia and death after allopurinol therapy. — J. A. M. A., 1970, 212, 478.

Kelley W. N. Effects of drugs on uric acid in man. — Ann. Pharmacol., 1975, 327.

Mills R. M. Severe hypersensitivity reactions associated with allopurinol. — J. A. M. A., 1971, 216, 799.

Nelson D. J., Elton G. B. Metabolism of (6 — 14C) allopurinol — Lack of incorporation of allopurinol into nucleic acids. — Biochem. Pharmacol., 1975, 24, 1235.

Smith M. I. V., Boyce W. H. Allopurinol and urolithiasis. — J. Urol., (Baltimore), 1969, 102, 750.

Tjandramaga Т. В., Cucinell S. A. Interaction of probenecid and allopurinal in gouty subjects. Federation Proceedings, 1971, 30, 392, Abstract 1112.

Vesell E. S., Passananti G. Т., Greene F. E. Impairment of drug metabolism in man by allopurinol and nortriptyline. — New Engl. J. Med., 1970, 283, 1484.

Watts R. W. E., Scott J. Т., Chalmers R. A. et al. Microscopic studies on skeletal muscle in gout patients treated with allopurinol. — Quart. J. Med., 1971, 40, 1.

«Лечение ревматических заболеваний»,
под ред. Ф.Д.Харта

Читайте далее: